Greenland Mines Ltd.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph A. Sinkule
- Full Time Employees
- 5
- Sector
- Basic Materials
- Industry
- Other Precious Metals
- Address
- 13576 Walnut Street Charlotte NE United States of America 68144
- IPO Date
- Apr 29, 2022
- CIK
- 0001907223
- Website
- greenlandmines.com
- Similar Companies
- Business
- Greenland Mines Ltd is a Nasdaq-listed strategic minerals explorer and developer focused on natural resources and cell and gene therapies. The company operates in two main divisions: Natural Resources, pursuing exploration and development opportunities in palladium, gold, and platinum deposits, including the Skaergaard Project in Southeast Greenland; and Cell and Gene Therapy, advancing biologic, cell, and gene therapies targeting neurodegenerative and age-related diseases such as Alzheimer's, ALS, and Parkinson's. Greenland Mines is headquartered in Frankfurt am Main, Germany, and established in 2019; it maintains geographic reach across Greenland, North America, Europe, and selected global markets through strategic partnerships and investor relations channels. The company’s principal products and services span mineral exploration and development activities, precious and strategic metal resource opportunities, and early- to mid-stage clinical and translational therapy programs, including partnerships with biomedical entities to advance KLTO-202 for ALS and related indications. Core offerings are organized as: mineral exploration rights and project development services; resource delineation, feasibility studies, and permitting support; project finance and investment opportunities for mineral assets; and research, development, and potential commercialization of cell and gene therapies in preclinical and clinical stages; and corporate services including investor outreach, strategic alliances, and licensing opportunities. Greenland Mines’ recent major changes include forming and expanding strategic alliances to accelerate mineral asset development in Greenland and associated jurisdictions, pursuing acquisitions and partnerships to broaden its asset base in lithium and rare earths, launching new programs or pilots in high-potential districts, and pursuing potential corporate restructurings to align with growth objectives; these actions reflect a shift toward accelerated value creation through asset diversification, enhanced capital deployment, and advancement of pipeline therapies. The company’s business segments address both commodity markets and biotechnology, with target markets comprising institutional investors, mining and metals customers, pharmaceutical and biotech partners, and governmental and regulatory bodies. Subsidiaries and parent relationships are oriented toward maintaining a public listing while leveraging strategic joint ventures and alliance agreements to maximize project value and therapy program progression. Greenland Mines’ operations are anchored in Greenland’s mineral districts, with ancillary activities in Canada and other jurisdictions to support project financing, regulatory compliance, and potential downstream opportunities; the company emphasizes geographic accessibility, robust governance, and transparent disclosure in line with Nasdaq-listed peers. This combined approach positions Greenland Mines as a dual-sector platform aiming to generate returns from high-value mineral discoveries while advancing novel therapeutic modalities for neurodegenerative and age-related diseases.
Greenland's Palladium Answer Just Got 31% Bigger, and Washington Is Watching
Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary
Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases
Greenland Mines Adds World Class Magmatic Researchers and Greenland Specialists to 2026 Skaergaard Field Campaign
A Drilling Crew, an Icebreaker, and a Path to an Open Pit at Skaergaard
A Drilling Crew, an Icebreaker, and a Path to an Open Pit at Skaergaard
Greenland Mines Concludes Three-Day Technical Workshop to Define and Advance Next Phase of Skaergaard Gold and Critical Metals Project Development
A Greenland Rare Earth Story Is Accelerating as the West Races to Break China's Magnet Grip
A Greenland Rare Earth Story Is Accelerating as the West Races to Break China's Magnet Grip
Greenland Mines Signs Drilling Contract with Nordisk Fundering for Expanded 2026 Skaergaard Diamond Drilling Program in Greenland
Greenland Mines (NASDAQ: GRML) Accelerates Sarfartoq Rare Earths Project Development with Updated S-K 1300 Resource Estimate Program
A Greenland Critical-Minerals Platform Is Taking Shape -- and It Just Pushed Into the Midstream Chokepoint
Greenland Mines Makes Strategic Investment in AnorTech, Adding Exposure to Sustainable Alumina, High Purity Alumina, and Midstream Critical Minerals Optionality
Greenland Mines Executes Strategic Downstream Agreement on Helguvik Industrial Complex in Iceland
Greenland Mines Completes Site Visit to Sarfartoq Nd-Pr Rare Earth Magnet Project in Greenland; Prepares 2026 Field Program
Greenland Mines Appoints WSP Denmark to Continue Environmental Baseline Work at the Sarfartoq Rare Earth Project
Nasdaq-Listed Critical Minerals Developer Lands Game-Changing Greenland Rare Earth Deal
Greenland Mines Signs Definitive Agreement to Acquire the Sarfartoq Neodymium-Praseodymium Rare Earths Project in Greenland
Greenland Mines Brings Skaergaard to EIT RawMaterials Summit 2026 in Brussels
The 5 Strategic Projects Quietly Defining the Next Decade of West's Critical Minerals Supply